Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study

Andrew B Lassman, Juan Manuel Sepúlveda-Sánchez, Timothy Cloughesy, Miguel J Gil-Gil, Vinay K Puduvalli, Jeffrey Raizer, Filip Y F De Vos, Patrick Y Wen, Nicholas Butowski, Paul M J Clement, Morris D Groves, Cristobal Belda-Iniesta, Pierre Giglio, Harris S Soifer, Steven Rowsey, Cindy Xu, Francesca Avogadri, Ge Wei, Susan Moran, Patrick Roth